rs191971593

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_014855.3(AP5Z1):​c.481G>A​(p.Val161Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00285 in 1,612,872 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0019 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0029 ( 10 hom. )

Consequence

AP5Z1
NM_014855.3 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:7

Conservation

PhyloP100: -1.83

Publications

6 publications found
Variant links:
Genes affected
AP5Z1 (HGNC:22197): (adaptor related protein complex 5 subunit zeta 1) This gene was identified by genome-wide screen for genes involved in homologous recombination DNA double-strand break repair (HR-DSBR). The encoded protein was found in a complex with other proteins that have a role in HR-DSBR. Knockdown of this gene reduced homologous recombination, and mutations in this gene were found in patients with spastic paraplegia. It was concluded that this gene likely encodes a helicase (PMID:20613862). [provided by RefSeq, Jan 2011]
AP5Z1 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 48
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0046389997).
BP6
Variant 7-4783430-G-A is Benign according to our data. Variant chr7-4783430-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 240943.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00192 (292/152260) while in subpopulation NFE AF = 0.00307 (209/67976). AF 95% confidence interval is 0.00273. There are 2 homozygotes in GnomAd4. There are 126 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014855.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AP5Z1
NM_014855.3
MANE Select
c.481G>Ap.Val161Met
missense
Exon 4 of 17NP_055670.1O43299-1
AP5Z1
NM_001364858.1
c.13G>Ap.Val5Met
missense
Exon 3 of 16NP_001351787.1
AP5Z1
NR_157345.1
n.574G>A
non_coding_transcript_exon
Exon 4 of 17

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AP5Z1
ENST00000649063.2
MANE Select
c.481G>Ap.Val161Met
missense
Exon 4 of 17ENSP00000497815.1O43299-1
AP5Z1
ENST00000865634.1
c.481G>Ap.Val161Met
missense
Exon 4 of 18ENSP00000535693.1
AP5Z1
ENST00000865636.1
c.481G>Ap.Val161Met
missense
Exon 4 of 17ENSP00000535695.1

Frequencies

GnomAD3 genomes
AF:
0.00191
AC:
291
AN:
152142
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000651
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00292
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00307
Gnomad OTH
AF:
0.00240
GnomAD2 exomes
AF:
0.00157
AC:
390
AN:
248262
AF XY:
0.00151
show subpopulations
Gnomad AFR exome
AF:
0.000519
Gnomad AMR exome
AF:
0.000957
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00241
Gnomad NFE exome
AF:
0.00255
Gnomad OTH exome
AF:
0.00166
GnomAD4 exome
AF:
0.00294
AC:
4300
AN:
1460612
Hom.:
10
Cov.:
32
AF XY:
0.00279
AC XY:
2028
AN XY:
726614
show subpopulations
African (AFR)
AF:
0.000598
AC:
20
AN:
33466
American (AMR)
AF:
0.000872
AC:
39
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86230
European-Finnish (FIN)
AF:
0.00317
AC:
167
AN:
52722
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5610
European-Non Finnish (NFE)
AF:
0.00353
AC:
3925
AN:
1111732
Other (OTH)
AF:
0.00237
AC:
143
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
285
570
856
1141
1426
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00192
AC:
292
AN:
152260
Hom.:
2
Cov.:
33
AF XY:
0.00169
AC XY:
126
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.000649
AC:
27
AN:
41572
American (AMR)
AF:
0.00124
AC:
19
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00292
AC:
31
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00307
AC:
209
AN:
67976
Other (OTH)
AF:
0.00237
AC:
5
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
16
32
47
63
79
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00219
Hom.:
0
Bravo
AF:
0.00173
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00389
AC:
15
ESP6500AA
AF:
0.000501
AC:
2
ESP6500EA
AF:
0.00312
AC:
26
ExAC
AF:
0.00142
AC:
171
EpiCase
AF:
0.00289
EpiControl
AF:
0.00314

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
2
1
Hereditary spastic paraplegia 48 (3)
-
-
1
AP5Z1-related disorder (1)
-
-
1
Hereditary spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.39
DANN
Benign
0.97
DEOGEN2
Benign
0.020
T
Eigen
Benign
-0.96
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.033
N
LIST_S2
Benign
0.57
T
M_CAP
Benign
0.0089
T
MetaRNN
Benign
0.0046
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.92
L
PhyloP100
-1.8
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.81
N
REVEL
Benign
0.045
Sift
Benign
0.23
T
Sift4G
Uncertain
0.014
D
Polyphen
0.67
P
Vest4
0.071
MVP
0.030
ClinPred
0.0036
T
GERP RS
-3.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.018
gMVP
0.19
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs191971593; hg19: chr7-4823061; COSMIC: COSV62241254; COSMIC: COSV62241254; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.